Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Association between chronic arsenic exposure and the characteristic features of asthma.

Siddique AE, Rahman M, Hossain MI, Karim Y, Hasibuzzaman MM, Biswas S, Islam MS, Rahman A, Hossen F, Mondal V, Banna HU, Huda N, Hossain M, Sultana P, Nikkon F, Saud ZA, Haque A, Nohara K, Xin L, Himeno S, Hossain K.

Chemosphere. 2020 May;246:125790. doi: 10.1016/j.chemosphere.2019.125790. Epub 2019 Dec 30.

PMID:
31918100
2.

Manganese attenuates the effects of arsenic on neurobehavioral and biochemical changes in mice co-exposed to arsenic and manganese.

Biswas S, Anjum A, Banna HU, Rahman M, Siddique AE, Karim Y, Nikkon F, Haque A, Hossain K, Saud ZA.

Environ Sci Pollut Res Int. 2019 Oct;26(28):29257-29266. doi: 10.1007/s11356-019-06112-y. Epub 2019 Aug 8.

PMID:
31396869
3.

Dose-dependent relationships between chronic arsenic exposure and cognitive impairment and serum brain-derived neurotrophic factor.

Karim Y, Siddique AE, Hossen F, Rahman M, Mondal V, Banna HU, Hasibuzzaman MM, Hosen Z, Islam MS, Sarker MK, Nikkon F, Saud ZA, Xin L, Himeno S, Hossain K.

Environ Int. 2019 Oct;131:105029. doi: 10.1016/j.envint.2019.105029. Epub 2019 Jul 25.

4.

Higher risk of hyperglycemia with greater susceptibility in females in chronic arsenic-exposed individuals in Bangladesh.

Paul SK, Islam MS, Hasibuzzaman MM, Hossain F, Anjum A, Saud ZA, Haque MM, Sultana P, Haque A, Andric KB, Rahman A, Karim MR, Siddique AE, Karim Y, Rahman M, Miyataka H, Xin L, Himeno S, Hossain K.

Sci Total Environ. 2019 Jun 10;668:1004-1012. doi: 10.1016/j.scitotenv.2019.03.029. Epub 2019 Mar 4.

PMID:
31018442
5.

British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non-infectious complications of common variable immunodeficiency disorders.

Bethune C, Egner W, Garcez T, Huissoon A, Jolles S, Karim Y, Jain R, Savic S, Kelley K, Grosse-Kreul D, Grigoriadou S.

Clin Exp Immunol. 2019 Jun;196(3):328-335. doi: 10.1111/cei.13272. Epub 2019 Mar 7.

6.

Butyrylcholinesterase-a potential plasma biomarker in manganese-induced neurobehavioral changes.

Anjum A, Biswas S, Rahman M, Rahman A, Siddique AE, Karim Y, Aktar S, Nikkon F, Haque A, Himeno S, Hossain K, Saud ZA.

Environ Sci Pollut Res Int. 2019 Mar;26(7):6378-6387. doi: 10.1007/s11356-018-04066-1. Epub 2019 Jan 7.

PMID:
30617895
7.

Mannose-binding lectin deficiency and predisposition to recurrent infection in adults.

Holdaway J, Deacock S, Williams P, Karim Y.

J Clin Pathol. 2016 Aug;69(8):731-6. doi: 10.1136/jclinpath-2015-203065. Epub 2016 Feb 2.

PMID:
26837313
8.

Doxepin may be a useful pharmacotherapeutic agent in chronic urticaria.

Adhya Z, Karim Y.

Clin Exp Allergy. 2015 Aug;45(8):1370. doi: 10.1111/cea.12580. No abstract available.

PMID:
26040550
9.

Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection.

Simoes J, Sciascia S, Camara I, Baldovino S, Karim Y, Roccatello D, Cuadrado MJ.

J Clin Rheumatol. 2015 Jan;21(1):35-7. doi: 10.1097/RHU.0000000000000201. No abstract available.

10.

Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.

Camara I, Sciascia S, Simoes J, Pazzola G, Salas V, Karim Y, Roccatello D, Cuadrado MJ.

Clin Exp Rheumatol. 2014 Jan-Feb;32(1):41-7. Epub 2013 Sep 12.

PMID:
24029366
11.

Phenindione interferes with measurement of creatinine.

Sankaralingam A, Karim Y, Swaminathan R.

Clin Biochem. 2013 Dec;46(18):1912-3. doi: 10.1016/j.clinbiochem.2013.08.017. Epub 2013 Sep 6. No abstract available.

PMID:
24016729
12.

The relationship between pro-resorptive inflammatory cytokines and the effect of high dose vitamin D supplementation on their circulating concentrations.

Karim Y, Turner C, Dalton N, Roplekar R, Sankaralingam A, Ewang M, Fogelman I, Hampson G.

Int Immunopharmacol. 2013 Nov;17(3):693-7. doi: 10.1016/j.intimp.2013.08.010. Epub 2013 Sep 3.

PMID:
24007780
13.

A case of atypical tardive seizure activity during an initial ECT titration series.

Thisayakorn P, Karim Y, Yamada T, McCormick LM.

J ECT. 2014 Mar;30(1):77-80. doi: 10.1097/YCT.0b013e31829c10d6.

PMID:
23845940
14.

Maintenance electroconvulsive therapy in a patient with multiple system atrophy and bipolar disorder.

Obiora O, McCormick LM, Karim Y, Gonzales P, Beeghly J.

J ECT. 2012 Jun;28(2):e1-2. doi: 10.1097/YCT.0b013e31824b64d7.

PMID:
22622294
15.

Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers.

Sciascia S, Ceberio L, Garcia-Fernandez C, Roccatello D, Karim Y, Cuadrado MJ.

Autoimmun Rev. 2012 Dec;12(2):157-63. doi: 10.1016/j.autrev.2012.03.009. Epub 2012 Apr 1. Review.

16.

Comparison of blind tracheal intubation through the intubating laryngeal mask airway (LMA Fastrach™) and the Air-Q™.

Karim YM, Swanson DE.

Anaesthesia. 2011 Mar;66(3):185-90. doi: 10.1111/j.1365-2044.2011.06625.x.

17.

Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.

Albon S, Bunn C, Swana G, Karim Y.

J Immunol Methods. 2011 Feb 28;365(1-2):126-31. doi: 10.1016/j.jim.2010.12.010. Epub 2010 Dec 22.

PMID:
21184759
18.

The role of immune complexes in atherogenesis.

Burut DF, Karim Y, Ferns GA.

Angiology. 2010 Oct;61(7):679-89. doi: 10.1177/0003319710366124. Epub 2010 Apr 14. Review.

PMID:
20395232
19.

Cow's milk allergy in children. Challenge is not crucial.

Karim Y, Adhya Z.

BMJ. 2009 Sep 7;339:b3622. doi: 10.1136/bmj.b3622. No abstract available.

PMID:
19736271
20.

Beyond immunosuppression - challenges in the clinical management of lupus nephritis.

Masood S, Jayne D, Karim Y.

Lupus. 2009 Feb;18(2):106-15. doi: 10.1177/0961203308095330. Review.

PMID:
19151111
21.

Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil.

Pisoni CN, Obermoser G, Cuadrado MJ, Sanchez FJ, Karim Y, Sepp NT, Khamashta MA, Hughes GR.

Clin Exp Rheumatol. 2005 May-Jun;23(3):393-6.

PMID:
15971430
22.

Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.

Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR.

J Rheumatol. 2005 Jun;32(6):1047-52.

PMID:
15940766
23.

Mycophenolate mofetil and systemic lupus erythematosus: an overview.

Pisoni CN, Karim Y, Cuadrado MJ.

Lupus. 2005;14 Suppl 1:s9-11. Review.

PMID:
15803925
24.

Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.

Cuadrado MJ, Karim Y, Sanna G, Smith E, Khamashta MA, Hughes GR.

Am J Med. 2005 Mar;118(3):246-50.

PMID:
15745722
25.

The NIH pulse cyclophosphamide regime: the end of an era?

Karim Y, D'Cruz DP.

Lupus. 2004;13(1):1-3. No abstract available.

PMID:
14870910
26.

Normal complement C4 values do not exclude hereditary angioedema.

Karim Y, Griffiths H, Deacock S.

J Clin Pathol. 2004 Feb;57(2):213-4.

27.

Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis.

Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I, Khamashta MA, D'Cruz D, Hughes GR.

Ann Rheum Dis. 2003 Jun;62(6):556-60.

28.

Haemolytic uraemic syndrome following mumps, measles, and rubella vaccination.

Karim Y, Masood A.

Nephrol Dial Transplant. 2002 May;17(5):941-2. No abstract available.

PMID:
11981093
29.

The association of pure red cell aplasia with the antiphospholipid syndrome.

Walton T, Karim Y, Wright D, Khamashta M, Hughes G.

Lupus. 2001;10(12):899-901. No abstract available.

PMID:
11787886
30.

C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites.

Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, Pepys MB, Kooner JS.

Circulation. 2001 Jul 10;104(2):145-50.

PMID:
11447077
31.

Outpatient video-EEG monitoring in children.

Connolly MB, Wong PK, Karim Y, Smith S, Farrell K.

Epilepsia. 1994 May-Jun;35(3):477-81.

PMID:
8026391
32.

Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses.

Sattar SA, Springthorpe VS, Karim Y, Loro P.

Epidemiol Infect. 1989 Jun;102(3):493-505.

33.

Development of methods to study the survival of airborne viruses.

Ijaz MK, Karim YG, Sattar SA, Johnson-Lussenburg CM.

J Virol Methods. 1987 Nov;18(2-3):87-106.

PMID:
2828403
34.

Survival of human rhinovirus type 14 dried onto nonporous inanimate surfaces: effect of relative humidity and suspending medium.

Sattar SA, Karim YG, Springthorpe VS, Johnson-Lussenburg CM.

Can J Microbiol. 1987 Sep;33(9):802-6.

PMID:
2825955
35.

Effect of relative humidity on the airborne survival of rhinovirus-14.

Karim YG, Ijaz MK, Sattar SA, Johnson-Lussenburg CM.

Can J Microbiol. 1985 Nov;31(11):1058-61.

PMID:
3004682

Supplemental Content

Support Center